Developer of smarter detection technology designed to enhance patient safety. The technology offers decision support and reporting that flags inappropriate prescriptions, where the medications prescribed do not match the diagnosis, age, and gender of the patient. They also support intelligent workflows inside Electronic Patient Record systems by providing suggested medications and diagnoses, as well as…

Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with rare diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

Development of monoclonal antibody-based therapeutics

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics.

Owner and operator of a biotechnology company intended to focus on developing engineered organisms that safely and effectively treat diseases. The company’s genetically engineered organisms are controlled by small molecules over protein function and by generating biosensors that identify and improve new enzymatic activities, enabling healthcare providers to diagnose the disease easily and give proper…

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology.

Manufactures exoskeletons for spinal injury and industrial applications

Siemens’ molecular testing systems enable precise detection; monitoring of treatment efficacy; and selection of targeted, individualized treatment options.

Santen USA, located in Emeryville, CA, is an important part of our ophthalmic research and development efforts worldwide and the home of our regional business teams